170 related articles for article (PubMed ID: 8099613)
1. CD4 lymphocytopenia among injecting drug users in New York City.
Des Jarlais DC; Friedman SR; Marmor M; Mildvan D; Yancovitz S; Sotheran JL; Wenston J; Beatrice S
J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):820-2. PubMed ID: 8099613
[TBL] [Abstract][Full Text] [Related]
2. Implications of the revised surveillance definition: AIDS among New York City drug users.
Des Jarlais DC; Wenston J; Friedman SR; Sotheran JL; Maslansky R; Marmor M; Yancovitz S; Beatrice S
Am J Public Health; 1992 Nov; 82(11):1531-3. PubMed ID: 1359800
[TBL] [Abstract][Full Text] [Related]
3. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force.
Smith DK; Neal JJ; Holmberg SD
N Engl J Med; 1993 Feb; 328(6):373-9. PubMed ID: 8093633
[TBL] [Abstract][Full Text] [Related]
4. Estimation of time since infection using longitudinal disease-marker data.
Dubin N; Berman S; Marmor M; Tindall B; Des Jarlais D; Kim M
Stat Med; 1994 Feb; 13(3):231-44. PubMed ID: 7911249
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection.
Ho DD; Cao Y; Zhu T; Farthing C; Wang N; Gu G; Schooley RT; Daar ES
N Engl J Med; 1993 Feb; 328(6):380-5. PubMed ID: 8093634
[TBL] [Abstract][Full Text] [Related]
6. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
Alcabes P; Muñoz A; Vlahov D; Friedland G
Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
[TBL] [Abstract][Full Text] [Related]
7. CD4+ lymphocyte level and rate of decline as predictors of AIDS in intravenous drug users with HIV infection.
Alcabes P; Schoenbaum EE; Klein RS
AIDS; 1993 Apr; 7(4):513-7. PubMed ID: 8099488
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort Study.
O'Brien TR; Diamondstone L; Fried MW; Aledort LM; Eichinger S; Eyster ME; Hilgartner MW; White G; Di Bisceglie AM; Goedert JJ
Am J Hematol; 1995 Jul; 49(3):201-6. PubMed ID: 7604813
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections.
Spira TJ; Jones BM; Nicholson JK; Lal RB; Rowe T; Mawle AC; Lauter CB; Shulman JA; Monson RA
N Engl J Med; 1993 Feb; 328(6):386-92. PubMed ID: 8093635
[TBL] [Abstract][Full Text] [Related]
10. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
11. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
[TBL] [Abstract][Full Text] [Related]
12. Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985-1991.
Gachupin-Garcia A; Selwyn PA; Budner NS
AIDS; 1992 Aug; 6(8):843-8. PubMed ID: 1329849
[TBL] [Abstract][Full Text] [Related]
13. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic CD4+ T-lymphocyte depletion in a west African population.
Djomand G; Diaby L; N'Gbichi JM; Coulibaly D; Kadio A; Yapi A; Kanga JM; Boateng E; Diallo K; Kestens L
AIDS; 1994 Jun; 8(6):843-7. PubMed ID: 7916194
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection.
Duncan RA; von Reyn CF; Alliegro GM; Toossi Z; Sugar AM; Levitz SM
N Engl J Med; 1993 Feb; 328(6):393-8. PubMed ID: 8093636
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
17. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
[TBL] [Abstract][Full Text] [Related]
18. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
[TBL] [Abstract][Full Text] [Related]
19. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis-associated severe CD4+ T-lymphocytopenia in HIV-seronegative patients from Dakar. SIDAK Research Group.
Kony SJ; Hane AA; Larouzé B; Samb A; Cissoko S; Sow PS; Sané M; Maynart M; Diouf G; Murray JF
J Infect; 2000 Sep; 41(2):167-71. PubMed ID: 11023763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
